SEC EDGAR filings, ownership reports, and insider transactions for Agomab Therapeutics NV.
Recent SEC filings for Agomab Therapeutics NV including SCHEDULE 13D, 6-K, 424B4 and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13D | Open SCHEDULE 13D document | View SEC filing for SCHEDULE 13D | 17 Feb 2026 | 005-95508 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | FORM 6-K | 09 Feb 2026 | 09 Feb 2026 | 001-43098 |
| 424B4 | Open 424B4 document | View SEC filing for 424B4 | 424B4 | 06 Feb 2026 | 333-292790 | |
| CERT | Open CERT document | View SEC filing for CERT | 05 Feb 2026 | 001-43098 | ||
| 8-A12B | Open 8-A12B document | View SEC filing for 8-A12B | FORM 8-A12B | 03 Feb 2026 | 001-43098 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 30 Jan 2026 | 333-292790 | ||
| F-1/A | Open F-1/A document | Open XBRL data | View SEC filing for F-1/A | F-1/A | 29 Jan 2026 | 333-292790 | |
| F-1 | Open F-1 document | Open XBRL data | View SEC filing for F-1 | F-1 | 16 Jan 2026 | 333-292790 | |
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 17 Dec 2025 | 377-07291 | ||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 28 Oct 2025 | 377-07291 | ||
| DRS | Open DRS document | View SEC filing for DRS | 20 Jun 2024 | 377-07291 |
Agomab Therapeutics NV files with the SEC under CIK 0002020932. This page aggregates EDGAR filings and related ownership activity.